News

Search:
 Search

Regulatory Update | 13 June 2012

UK: NICE Revises Guidance on Amgen's Denosumab

0 Likes

The UK’s National Institute for Health and Clinical Excellence (NICE) has reversed an earlier decision and now plans to recommend the use of Amgen’s new cancer drug denosumab, used in the treatment of Read More...


RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more


New Regulatory Focus Apps for iPad and iPhone